Biohaven Ltd (BHVN)

Apr 05, 2026

Aug Spikes: What is the long term forecast for Biohaven Ltd stock2026 Update & Consistent Profit Trade Alerts - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

BHVN PE Ratio & Valuation, Is BHVN Overvalued - Intellectia AI

Apr 04, 2026

Apr 04, 2026

BHVN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Brain Neuro - Barchart.com

Apr 03, 2026

Apr 03, 2026

Why Biohaven (BHVN) Is Up 11.7% After Fully Enrolling Its Phase 2 Obesity Drug Trial - Sahm

Apr 03, 2026

Apr 02, 2026

Biohaven Ltd. (BHVN) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026

Apr 02, 2026

Citigroup Forecasts Strong Price Appreciation for Biohaven (NYSE:BHVN) Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

Citi Maintains Biohaven(BHVN.US) With Buy Rating, Raises Target Price to $17 - Moomoo

Apr 02, 2026

Apr 02, 2026

BHVN SEC FilingsBiohaven 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Apr 02, 2026

Biohaven Ltd. (BHVN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 02, 2026

Apr 02, 2026

BHVN Stock Price, Quote & Chart | BIOHAVEN LTD (NYSE:BHVN) - ChartMill

Apr 02, 2026

Apr 01, 2026

Biohaven (NYSE:BHVN) Shares Up 10.5%Here's Why - MarketBeat

Apr 01, 2026

Apr 01, 2026

Biohaven Jumps 10.9% Amid Robust Intraday Rally—What’s Driving This Upswing? - Bitget

Apr 01, 2026

Apr 01, 2026

Biohaven (BHVN) Fuels Confidence With Encouraging Azetukalner Data - Insider Monkey

Apr 01, 2026

Mar 31, 2026

Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy - MSN

Mar 31, 2026

Mar 31, 2026

Aug Final Week: Can Biohaven Ltd stock outperform in a bear market2026 Price Targets & Smart Investment Allocation Tips - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Investment Recap: Can Biohaven Ltd deliver alpha2026 Update & Accurate Intraday Trade Tips - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

Biohaven (BHVN) completes enrollment in phase 2 obesity study of taldefgrobep alfa - MSN

Mar 30, 2026

Mar 30, 2026

Breakout Zone: Can Biohaven Ltd be recession proofDip Buying & Weekly High Return Stock Forecasts - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Can Biohaven (BHVN) Redefine Obesity Treatment By Targeting Lean Mass Preservation With Taldefgrobep? - Yahoo Finance

Mar 29, 2026

Mar 29, 2026

Gains Recap: How does Biohaven Ltd score in quality rankingsLayoff News & Detailed Earnings Play Alerts - baoquankhu1.vn

Mar 29, 2026

Mar 28, 2026

Market Pulse: What are analysts price targets for Biohaven Ltd2026 Volatility Report & Risk Managed Trade Strategies - baoquankhu1.vn

Mar 28, 2026

Mar 28, 2026

The Technical Signals Behind (BHVN) That Institutions Follow - Stock Traders Daily

Mar 28, 2026

Mar 28, 2026

Biohaven shares edge higher after completing enrollment in obesity drug trial - MSN

Mar 28, 2026

Mar 27, 2026

Biohaven (BHVN) Completes Enrollment in Phase 2 Obesity Study of Taldefgrobep Alfa - Insider Monkey

Mar 27, 2026

Mar 26, 2026

Biohaven (NYSE:BHVN) Trading 6.2% HigherHere's Why - MarketBeat

Mar 26, 2026

Mar 25, 2026

Can Biohaven (BHVN) Redefine Obesity Treatment By Prioritizing Muscle Preservation Over Pure Weight Loss? - simplywall.st

Mar 25, 2026

Mar 25, 2026

JPMorgan Chase & Co. Sells 1,236,587 Shares of Biohaven Ltd. $BHVN - marketbeat.com

Mar 25, 2026

Mar 24, 2026

Assessing Biohaven (BHVN) Valuation As Losses Persist And Price To Book Hits 25x - simplywall.st

Mar 24, 2026

Mar 23, 2026

Biohaven Shares Drop 70%, Yet a Fund’s Fresh $6 Million Investment Hints at Possible Recovery - Bitget

Mar 23, 2026

Mar 23, 2026

Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential - The Motley Fool

Mar 23, 2026

Mar 23, 2026

Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential - The Motley Fool

Mar 23, 2026

Mar 23, 2026

Movement Recap: What is the long term forecast for Biohaven Ltd stockGDP Growth & Weekly High Return Stock Forecasts - baoquankhu1.vn

Mar 23, 2026

Mar 22, 2026

Biohaven Ltd. (NYSE:BHVN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 22, 2026

Mar 21, 2026

Biohaven’s robust cash reserves and unique degrader strategy ignite a strong value opportunity, with crucial 2026 clinical trials approaching - Bitget

Mar 21, 2026

Mar 21, 2026

Biohaven's 2026 Pivotal Trial Countdown: Can Capital Discipline Unlock a High-Risk, High-Reward Moat? - Bitget

Mar 21, 2026

Mar 21, 2026

DAFNA Capital Management Increases Biohaven Ltd. Investment in 2025News and Statistics - IndexBox

Mar 21, 2026

Mar 20, 2026

Biohaven Ltd.: Fundamental Analysis and Financial Ratings | BHVN34 | BRBHVNBDR001 - marketscreener.com

Mar 20, 2026

Mar 20, 2026

Biohaven completes enrollment in obesity drug trial By Investing.com - Investing.com India

Mar 20, 2026

Mar 19, 2026

Biohaven (NASDAQ: BHVN) director reports gifting 34,684 shares, adds family trust - Stock Titan

Mar 19, 2026

Mar 19, 2026

Risk Off: What is the long term forecast for Biohaven Ltd stock2026 Market WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn

Mar 19, 2026

Mar 19, 2026

Biohaven Therapeutics discloses prodrugs of betahistine - BioWorld MedTech

Mar 19, 2026

Mar 19, 2026

Biohaven Ltd. Completes Enrollment In Phase 2 Obesity Study With Taldefgrobep Alfa - marketscreener.com

Mar 19, 2026

Mar 19, 2026

Biohaven completes enrollment in obesity drug trial - Investing.com

Mar 19, 2026

Mar 19, 2026

Biohaven stock rises as obesity trial completes enrollment - Investing.com UK

Mar 19, 2026

Mar 19, 2026

Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment - PR Newswire

Mar 19, 2026

Mar 18, 2026

Biohaven has completed enrollment for its obesity study—However, the market still hasn't factored in the potential risk of the trial not succeeding - Bitget

Mar 18, 2026